The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2023

Filed:

Apr. 27, 2018
Applicants:

Vanderbilt University, Nashville, TN (US);

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

James E. Crowe, Jr., Nashville, TN (US);

Andrew Flyak, Nashville, TN (US);

Justin Bailey, Baltimore, MD (US);

Stuart Ray, Baltimore, MD (US);

George Shaw, Philadelphia, PA (US);

Assignees:

VANDERBILT UNIVERSITY, Nashville, TN (US);

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, Philadelphia, PA (US);

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/29 (2006.01); A61K 39/12 (2006.01); A61K 39/39 (2006.01); A61P 31/14 (2006.01); A61K 9/127 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 9/127 (2013.01); A61K 39/29 (2013.01); A61K 39/39 (2013.01); A61P 31/14 (2018.01); A61K 9/0019 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55555 (2013.01);
Abstract

The present disclosure relates to compositions and methods for inducing an adaptive immune response against Hepatitis C virus (HCV) in a subject. In some embodiments, the present disclosure provides a composition comprising a nucleic acid molecule encoding a HCV antigen, an HCV antigen, an adjuvant, or a combination thereof. For example, in some embodiments, the composition comprises a vaccine comprising a nucleic acid molecule encoding a HCV antigen, an HCV antigen, an adjuvant, or a combination thereof.


Find Patent Forward Citations

Loading…